Back to Show
PBS News Hour
FDA criticized for Alzheimer's drug approval process
New findings from a congressional investigation into the Food and Drug Administration and the biotech company Biogen find the FDA broke its own protocols to approve a new Alzheimer’s drug last year. The report said the FDA worked too closely with Biogen despite significant concerns over the limited benefits and side effects of the new drug, Aduhelm. Geoff Bennett reports.
Support Provided By
Season

57:46
March 13, 2025 - PBS News Hour full episode

57:46
March 12, 2025 - PBS News Hour full episode

57:46
March 11, 2025 - PBS News Hour full episode

57:46
March 10, 2025 - PBS News Hour full episode

24:09
March 9, 2025 - PBS News Weekend full episode

24:09
March 8, 2025 - PBS News Weekend full episode

57:46
March 7, 2025 - PBS News Hour full episode

57:46
March 6, 2025 - PBS News Hour full episode

56:45
March 5, 2025 - PBS News Hour full episode

57:46
March 4, 2025 - PBS News Hour full episode

57:46
March 3, 2025 - PBS News Hour full episode

24:08
March 2, 2025 - PBS News Weekend full episode